Watchlist Price Alert

XTL Biopharmaceuticals Lt... (XTLB)

NASDAQ: XTLB · Real-Time Price · USD

1.23

0.01 (0.82%)

At close: Jun 17, 2025, 2:24 PM

XTL Biopharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	371K	1.4M	2.09M	2.97M	3.63M	4.46M	3.25M	3.29M	2.02M
Short-Term Investments	772K	605K	1.63M	3.16M	2.41M	2.27M	4.87M	2.81M	414K
Long-Term Investments	14K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Receivables	99K	n/a	71K	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	85K	130K
Other Current Assets	47K	11K	14K	16K	13K	20K	n/a	n/a	191K
Total Current Assets	1.34M	2.05M	3.81M	6.24M	6.12M	6.83M	8.2M	6.21M	2.75M
Property-Plant & Equipment	187K	n/a	n/a	1K	2K	2K	n/a	n/a	10K
Goodwill & Intangibles	7.01M	380K	380K	380K	380K	380K	380K	380K	253K
Total Long-Term Assets	7.21M	380K	380K	381K	382K	382K	380K	380K	263K
Total Assets	8.55M	2.43M	4.19M	6.62M	6.5M	7.21M	8.57M	6.59M	3.02M
Account Payables	196K	1K	2K	2K	2K	1K	253K	4K	17K
Deferred Revenue	18K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	138K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	1.33M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	2.21M	206K	187K	231K	254K	232K	253K	300K	330K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	689K	n/a	n/a	1.05M	2.64M	n/a	n/a	2.67M	n/a
Total Long-Term Liabilities	908K	n/a	n/a	1.05M	2.64M	n/a	n/a	2.67M	n/a
Total Liabilities	3.12M	206K	187K	1.28M	254K	232K	253K	2.97M	330K
Total Debt	138K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	23.14M	14.12M	14.12M	14.12M	13.18M	13.18M	13.18M	13.18M	6.62M
Retained Earnings	-159.01M	-158.25M	-156.47M	-155.13M	-154.66M	-153.93M	-152.59M	-155.65M	-154.9M
Comprehensive Income	20K	20K	20K	20K	20K	20K	20K	67K	183K
Shareholders Equity	5.43M	2.22M	4M	5.33M	6.25M	6.98M	8.32M	3.62M	2.69M
Total Investments	786K	605K	1.63M	3.16M	2.41M	2.27M	4.87M	2.81M	414K